Ischemic & Hemorrhagic Stroke in Pts on Oral Anticoagulants After Reconstruct for Chronic Lower Limb Ischemia
Stroke 24:1655-1663, Dawson,I.,et al, 1993
When Life Support is Questioned Early in the Care of Patients with Cervical-Level Quadriplegia
NEJM 328:506-509, Patterson,D.R.,et al, 1993
Laboratory Monitoring of Oral Anticoagulant Therapy:Are We Being Misled?
Neurol 43:468-470, Albers,G.W., 1993
Effect of Low-Intensity Warfarin Anticoag on Level of Activity of Hemostatic System in Pts with Atrial Fib
Stroke 24:1360-1365, Kistler,J.P.,et al, 1993
Safety of Anticoagulation After Hemorrhagic Infarction
Neurol 43:1298-1303, Pessin,M.S.,et al, 1993
Coagulation Abnormalities and Cerebral Infarction
JNNP 56:433-439, Greaves,M., 1993
Complications of Therapy for Venous Thromboembolic Disease in Patients with Brain Tumors
Neurol 43:1111-1114, Levin,J.M.,et al, 1993
The Antiphospholipid Syndrome:Ten years On
Lancet 342:341-344, Hughes,G.R.V., 1993
Effect of Laboratory Variation in the Prothrombin-Time Ratio on the Results of Oral Anticoagulant Therapy
NEJM 329:696-702, Eckman,M.H.,et al, 1993
The Management of Acute Visual Failure
JNNP 56:234-240, Wray,S.H., 1993
Anticoagulant-Related Bleeding:Clinical Epidemiology, Prediction, and Prevention
Am J Med 95:315-328, Landefeld,C.S.&Beyth,R.J., 1993
Deep Cerebral Venous System Thrombosis:Case Report
Neurosurgery 33:911-913, Brown,J.I.M.,et al, 1993
Efficacy of Ticlopidine & Aspirin for Prev of Rev Cerebrovascular Ischemic Events, Ticlopidine Aspirin Study
Stroke 24:1452-1457, Bellavance,A.,et al, 1993
How Twin Cities Neurologists Treat Ischemic Stroke, Policies and Trends
Arch Neurol 50:1098-1103, Anderson,D.C., 1993
Secondary Prevention in Non-Rheumatic Atrial Fib After TIA or Minor Stroke
European Atrial Fibrillation Trial Study Group, Lancet 342:1255-1262, 1251-1252993., , 1993
Acute Behaviour Disturbances
JNNP 56:1149-1156, Lloyd,G.G., 1993
Antithrombotic Therapy in Acute Ischaemic Stroke:An Overviews of the Completed Randomized Trials
JNNP 56:17-25, Sandercock,P.A.G.,et al, 1993
Risk Factors for Complications of Chronic Anticoagulation
Ann Int Med 118:511-520, Fihn,S.D.,et al, 1993
Lupus Anticoagulant and the Fibrinolytic System in Young Patients with Stroke
Stroke 24:368-370, Ferro,D.,et al, 1993
The Efficacy & Safety of Ticlopidine & Aspirin in Non-Whites:Subgroup from Ticlopidine Aspirin Stroke Study
Neurol 43:27-31, Weisberg,L.A., 1993
Failure of High-Dose Heparin to Prevent Recurr Cardioembolic Strokes in Preg Pt with Mech Heart Valve
Neurol 42:2204-2206, Golby,A.J.,et al, 1992
Stroke Complic Acute MI, A Meta-Analysis of Risk Modific by Antigoac & Thrombolytic Therapy
Arch Int Med 152:2020-2024, Viatkus,P.T.,et al, 1992
Cost Effectiveness of Primary Stroke Prevention in Atrial Fibrillation
BMJ 305:1457-1460, 14451992., Gustafsson,C.,et al, 1992
Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial Fibrillation
NEJM 327:1406-1412, 14511992., Ezekowitz,M.D.,et al, 1992
Anticoagulant Treatment as a Risk Factor for Primary Intracerebral Hemorrhage
JNNP 55:1121-1124, Fogelholm,R.,et al, 1992
Two Alien Hand Syndromes
Neurol 42:19-24, Feinberg,T.E.,et al, 1992
Reliance on Prothrombin Time Ratios Causes Significant Errors in Anticoagulation Therapy
Arch Int Med 152:278-282, 2571992., Bussey,H.I.,et al, 1992
Migraine, Suicidal Ideation, and Suicide Attempts
Neurol 42:392-395, Breslau,N., 1992
Cerebral Venous Thrombosis in Behcet's Disease:Clinical Study and Long-Term Follow-Up of 25 Cases
Neurol 42:614-618, Wechsler,B.,et al, 1992
Secondary Prevention of Stroke
Lancet 339:724-727, Warlow,C., 1992
Suicide and Multiple Sclerosis:An Epidemiological Investigation
JNNP 55:542-545, Stenager,E.N.,et al, 1992
Juvenile Fire Setting and the Photoparoxysmal Response
Ann Neurol 32:222-223, Milrod,L.M.&Urion,D.K., 1992
Cerebral Venous Thrombosis
Neurol Clin 10:87-111, Ameri,A.&Bousser,M-G., 1992
Carotid Endarterectomy:Recommendations for Manag of Transient Ischaemic Attack and Ischaemic Stroke
BMJ 305:1071-1074, Brown,M.M.,et al, 1992
Ticlopidine vs Aspirin for Prevention of Recurrent Stroke, Analysis of Pts with Stroke from Ticlopidine Aspirin Study
Stroke 23:1723-1727, Harbison,J.W., 1992
Effects of Low-to-High Doses of Aspirin on Platelet Aggregab & Metabol of Thromboxane A2 & Prostacyclin
Stroke 23:1400-1403, Tohgi,H.,et al, 1992
Low-Dose Aspirin and Stroke"It Ain't Necessarily So"
Stroke 23:1395-1399, Dyken,M.L.,et al, 1992
Cardiogenic Embolism to the Brain
Lancet 339:589-594, Hart,R.G., 1992
Lupus Anticoagulant and Anticardiolipin Antibodies in Young Adults with Cerebral Ischemia
Stroke 23:189-193, Nencini,P.,et al, 1992
Predictors of Thromboembolism in Atrial Fibrillation:I. Clinical Features of patients at Risk
The Stroke Prevention in A Fib Investigators, Ann Int Med 116:1-51992., , 1992
Role of Ticlopidine for Prevention of Stroke
Stroke 23:912-916, Albers,G.W., 1992
European Stroke Prevention Study:Effectiveness of Antiplatelet Therapy in Diabetics in Secondary Prevent of Stroke
Stroke 23:851-854, Sivenius,J.,et al, 1992
Safety & Efficacy of Intravenous Tissue Plasminogen Activator & Heparin in Acute Middle Cerebral Artery Stroke
Stroke 23:646-652, vonKummer,R.&Hacke,W., 1992
Emergency Reversal of Anticoagulation aftr Intracerebral Hemorrhage
Stroke 23:972-977, Fredriksson,K.,et al, 1992
Ticlopidine for Prevention of Stroke
The Medical Letter, 34:65-661992., , 1992
A Critical Appraisal of Ticlopidine, A New Antiplat Agent, Effectiveness & Clin Indic for Prophylaxis
Arch Int Med 152:1376-1380, Haynes,R.B.,et al, 1992
Central Nervous System Disease in Patients with Systemic Lupus Erythematosus
Neurol 42:1649-1657, Futrell,N.,et al, 1992
Antiphospholipid Antibody Syndrome
JAMA 268:1451-1453, Lockshin,M.D., 1992
Behavior Changes Following Temporal Lobectomy, With Special Reference to Psychosis
JNNP 55:89-91, Trimble,M.R., 1992
Prevention of Stroke with Ticlopidine:Who Benefits Most?
Neurol 42:111-115, Grotta,J.C.,et al, 1992